{"anticipatedPostingDate":"2026-12","denomUnitsSelected":"Participants","description":"EFS is defined as time from randomization to the first documented local recurrence or occurrence of distant kidney cancer metastasis(es) among participants which by BICR were considered disease-free at baseline (M0/M1 NED); or disease progression among participants which by BICR were considered to have baseline disease (M1), or death due to any cause, whichever occurs first.","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 72 months","title":"Event-Free Survival (EFS) as Assessed by the Blinded Independent Central Review (BICR)","type":"SECONDARY"}